PI Industries Limited

rs,

PI External Inspired by Science BSE Limited Corporate Relationship Deptt. PJ Towers, 25th Floor, Dalal Street, Mumbai – 400 001 National Stock Exchange of India Ltd. Exchange Plaza,

0.2%

ned execution Inspired by Science Figures in Rs. Million Revenue EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products

4%

ence Figures in Rs. Million Revenue EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products in Exports and 6 in Domest

8%

es in Rs. Million Revenue EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products in Exports and 6 in Domestic Agri Bra

9%

n Rs. Million Revenue EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products in Exports and 6 in Domestic Agri Brands

17%

on Revenue EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products in Exports and 6 in Domestic Agri Brands New product

1%

EBITDA PAT *Q3FY25 19,008 0.2% 5,122 *9MFY25 61,907 4% 17,264 8% 9% 3,727 17% 13,297 1% Commercialised 6 new products in Exports and 6 in Domestic Agri Brands New products in Agchem

40%

new products in Exports and 6 in Domestic Agri Brands New products in Agchem Exports growing ~40% Y-o-Y Biologicals revenue in Domestic grew by ~20% Y-o-Y Trade working capital improved to 68

20%

ds New products in Agchem Exports growing ~40% Y-o-Y Biologicals revenue in Domestic grew by ~20% Y-o-Y Trade working capital improved to 68 days from 80 days Cash flow from operating activiti

Rs. 12,482 million

l improved to 68 days from 80 days Cash flow from operating activities in 9MFY25 increased to Rs. 12,482 million * Consolidated Financials; Agrochemicals Q3FY25 Revenue is up 4% and EBITDA is flat 3 Consolidat

25 %

f Domestic revenues - - - - - - - - - - - - - - - - - - - - - - - Fig in Rs. Million Q3FY24 Q3FY25 % YOY ▪ Overall flat revenue (3-year Q3 CAGR 12%). Revenue Gross Margin Overheads EBITDA EBITD

12%

- - - - - - - - Fig in Rs. Million Q3FY24 Q3FY25 % YOY ▪ Overall flat revenue (3-year Q3 CAGR 12%). Revenue Gross Margin Overheads EBITDA EBITDA as % of Revenue Net Profit 18,975 19,008

“FY25 in Sustainable Agriculture project • ~30,000 trees planted for a significant positive impact on the environment Classification | PI Confidential 24 24 Rewards and Recognition a Inspired by Science Most Promising Company of the Year by CNBC TV18 India Business Leader Awards (IBLA) ...”

CSM Export

1

Domestic

1

Health Science

1

CSM Export

Technology focused approach to drive incremental business • Demand expected to improve in second half of CY25 • Continued scale-up of products commercialized over the last 3-years • Capacity expansion in line with plan • Momentum in new enquiries and conversions

Domestic

Focus on portfolio diversification with high quality revenue • Stable commodity prices coupled with higher reservoir levels to drive agri-sector • New launches and focus on biologicals to drive growth • Overall price pressure will continue in the generics space • Focus on quality of revenue with disciplined NWC management

Health Science

Building a differentiated play in Pharma CDMO space • Normalisation of product inventory levels in coming quarters • Build-up of pipeline projects for CRO and CDMO • Progressing on the mid to long term growth path Progressing on strategic initiatives in line with plan • Technology development to build new frontiers of growth • Progress on R&D leads for potential commercialisation • Strong pipeline of Biological products at different stages of development • Continue evaluating a few inorganic growth opportunities … cautiously progressing to achieve single-digit revenue growth for FY25 17 PI the company An organization that is committed to excellence in whatever it does . . . Inspired by Science known for over 2 decades to be the Top wealth creator . . . “Outshines competitors in delivering business needs of the customers by unlocking value & fearlessly reinventing ourselves ” A Trusted Brand & Partnerships Successful product Brands & Services Science & Technology ESG • 5+ decades of rel